Jon Napitupulu

HUTCHMED will field a broad slate of oncology and hematology data at ESMO Asia and ASH 2025, spotlighting multiple...

CMS has moved to add catheter ablation for atrial fibrillation to the list of reimbursable procedures in Ambulatory Surgical...

HUTCHMED will bring a broad slate of oncology and hematology readouts to ESMO Asia (December 5–7, Singapore) and ASH...

Orchestra BioMed granted stock options covering 151,250 shares to 12 newly hired employees on November 24 under its 2025...

BioVersys has dosed the first healthy volunteer in a China-based Phase 1 study of BV100, an intravenous rifabutin formulation...

Orchestra BioMed has issued stock options for 151,250 shares to 12 new hires under a Nasdaq-compliant inducement plan, with...

SciSparc has signed a binding term sheet to acquire a portfolio of patents, trademarks, and know-how from Xylo Technologies,...

Tangram Therapeutics has submitted a Clinical Trial Application to the UK’s MHRA for TGM-312, a GalNAc-conjugated siRNA targeting a...

Nurexone Biologic reported a busy third quarter: the exosome-focused biotech secured roughly C$4.6 million in fresh capital through accelerated...

PolyPid will host a virtual KOL event on December 10 to spotlight D-PLEX100, its locally delivered doxycycline depot designed...